Hikma Pharmaceutical
HIK
Delayed London Stock Exchange - 05/25 05:35:06 pm
1665GBp
-0.36%
Prev.1671.0000
Open1674.0000
High1676.7999
Low1643.0000
Volume989 044
Last news
Financials
Sales 2017 2 093 M
EBIT 2017 419 M
R. net 2017 227 M
Debt 2017 475 M
Rend. 2017 1,47%
P/E ratio 2017 22,29
P/E ratio 2018 16,42
EV / Sales 2017 2,71x
EV / Sales 2018 2,43x
Capitalization 5 205 M
Company
Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products.It operates through the following segments: Branded, Injectables, Generics, and Others.The Branded segment offers selling of branded generics and in-licensed...
Sector :
Pharmaceuticals - NEC
Calendar : 2017-08-17 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishNeutral
Resistance1 8211 9892 634
Spread/Res.-8,6%-16%-37%
Spread/Supp.0,54%0,54%2,4%
Support1 6561 6561 626